Navigation Links
PharmaDerm Launches Co-Pay Rebate Programs
Date:7/11/2011

FLORHAM PARK, N.J., July 11, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today the availability of prescription drug assistance programs to reduce health insurance co-payments for six primary dermatological brands. Under the programs, patients will pay $10 - $30 out-of-pocket for ADOXA® 150mg (doxycycline capsules), APEXICON® E (diflorasone diacetate USP 0.05% [emollient]) CREAM, CUTIVATE® (fluticasone propionate) LOTION, 0.05%, OXISTAT® (oxiconazole nitrate) CREAM, 1% and LOTION, 1%, SOLARAZE® (diclofenac sodium) Gel, 3%, and VEREGEN® (sinecatechins) Ointment, 15%.

The programs reduce the patient's out-of-pocket costs through the use of Instant Savings Cards. These cards can be obtained directly from a doctor's office and are used in conjunction with a valid prescription.  Patients present the card to their pharmacist when filling the prescription and have their co-pay or out-of-pocket cost reduced.

"PharmaDerm listens to our community of physicians and patients to help us assess their challenges and potential obstacles to treatment. We recognize that one such challenge involves prescription co-pay expenses, which may be prohibitive for some insured patients," said Steve Andrzejewski, CEO of Nycomed US. "The co-pay assistance programs demonstrate our commitment to being responsive to the needs of both the prescribers and the users who may benefit from our medications, which treat some of the more common skin conditions affecting patients today."

Any individual with prescription drug benefits coverage requiring a patient co-payment is eligible to participate in the programs. Terms and conditions (e.g., co-pay amount, eligibility requirements, limits on number of prescriptions and prescription refills, program activation and expiration dates) vary by product.

To learn more about the co-pay assistance programs and to obtain Instant Savings Cards, physicians can contact their local PharmaDerm sales representative or call customer service at 1-800-645-9833. Patients who have questions about the programs can also call the customer service toll-free number.

About Nycomed US

Nycomed US Inc. is a subsidiary of Nycomed and operates two divisions in the United States focused on specialty pharmaceuticals in dermatology.  Founded in 1849, Fougera is a division of Nycomed US Inc. and is the leading manufacturer and distributor of a wide range of topical products.  The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body.  For more information on Fougera's complete line of products, please call Fougera Customer Service at (800) 645-9833 or visit the company online at www.fougera.com.  Information on PharmaDerm products can be found online at www.pharmaderm.com.  More information is also available at www.nycomedus.com.

Contact:
Mona Daniels
PharmaDerm, a division of Nycomed US Inc.
(973) 514-4272

Kaitlyn Techtmann
MSL New York
(212) 468-3244


'/>"/>
SOURCE PharmaDerm
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Launches VersiTomic G-Lok™
2. ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions
3. Lupin Launches Additional Strengths of Generic Lotrel® Capsules
4. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
5. Global Medical Imaging Launches Worlds First Ultrasound Maintenance App
6. UCB Launches Research Alliance with Harvard University
7. Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System
8. Hocoma Launches New Version of its Established Gait Training Device LokomatPro
9. American Pain Foundation Launches New Educational Campaign, "Explain Your Pain," to Help Hispanic Americans Better Understand Chronic Pain and Pain Management
10. ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities
11. MCRA Launches Compliance and Business Ethics Hotline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... England och PITTSBURGH ... Erbjudandet lämnas inte, och detta pressmeddelande ... indirekt, i eller till, och inga anmälningssedlar ... av aktieägare i, något land där Erbjudandet, ... accept av Erbjudandet skulle strida mot tillämpliga ...
(Date:2/10/2016)... February 10, 2016 A new report from business intelligence ... states that the Alzheimer,s disease market will more than double from just under ... Compound Annual Growth Rate (CAGR) of 11%. Canada , ... , Spain , the UK, and Japan ... forecast period. --> Canada , France ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , ... in the North Metro Denver area. The new dental practice focuses on comfort where ... in the most relaxing environment. , While some dental visits can create anxiety for ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
Breaking Medicine News(10 mins):